BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October

Day

• 1
• 2
• 3
• 5
• 6
• 7
• 8
• 9
• 10
• 13
• 14
• 15
• 16
• 17
• 19
• 20
• 21
• 22
• 23
• 24
• 26
• 27
• 28
• 29
• 30
• 31

• Press Releases

  Aprea Therapeutics Provides ACESOT-1051 Program Update for WEE1 Inhibitor APR-1051: Accelerating and Expanding Enrollment. Clinical Data Presentation Planned for Q4 2026

  July 30, 2026

   · 

  8 min read
• Press Releases

  Verrica Pharmaceuticals to Report Second Quarter 2026 Financial Results and Provide a Corporate Update on August 6, 2026

  July 30, 2026

   · 

  1 min read
• Press Releases

  MIRA Pharmaceuticals Progresses MIRA-55 and SKNY-1 Toward IND-Enabling Studies

  July 30, 2026

   · 

  7 min read
• Press Releases

  CorVascular Launches ASUS Handheld Ultrasound Portfolio for Vascular Specialists at SVU 2026

  July 30, 2026

   · 

  3 min read
• Press Releases

  Anavex Life Sciences Reports Preliminary Second Quarter 2026 Financial Results and Provides Business Update

  July 30, 2026

   · 

  12 min read
• Press Releases

  MMI Receives FDA Approval to Advance to Phase II of Patient Enrollment in Groundbreaking REMIND Microsurgical Study in Alzheimer’s Patients

  July 30, 2026

   · 

  3 min read
• Press Releases

  EVERSANA Selected by Innovacell as Commercialization Partner to Advance Novel Cell Therapy ICEF15 in the United States

  July 30, 2026

   · 

  3 min read
• Press Releases

  Sumitomo Pharma America Announces Enzomenib (DSP-5336) Receives FDA Orphan Drug Designation for Treatment of Acute Lymphoblastic Leukemia

  July 30, 2026

   · 

  5 min read
• Press Releases

  Savara Announces European and Australian Patent Offices Have Granted Patents for the Liquid Formulation of MOLBREEVI*, Providing Protection in Europe and Australia Until March 2041

  July 30, 2026

   · 

  5 min read
• Press Releases

  Resilience and Lilly Invest $750 Million to Increase U.S.-Manufactured Medicine Supply

  July 30, 2026

   · 

  4 min read